News of Note—PCI and ADC Bio add to manufacturing; recalls up

newspapers
(Pixabay)

> CDMO PCI Pharma Services began work Nov. 12 on a 30,000-square-foot expansion of its facility in Rockford, Illinois, that will add primary and secondary packaging and labeling of clinical supply and includes a temperature-controlled suite. Release

> ADC Biotechnology, which is working on a new and what it calls improved way to manufacture antibody-drug conjugates, has gotten £2.5 million from existing investors that will help it add a filling line to its manufacturing operation in Deeside, North Wales. Release

> Pharmaceutical recalls rose 19% in the third quarter, while recalled units fell 56% to just over 7 million, according to a survey by Stericycle Expert Solutions. Release

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

Suggested Articles

Neopharma, which has been buying and building plants for several years, is buying a sterile injectables plant and assets in Japan from India’s Lupin. 

Already knocked by the FDA four times this year, Dr. Reddy’s now has a fifth Form 483 to dwell on. This time it’s at a plant with a history of faults.

In a warning letter, the FDA details how a Chinese OTC drugmaker handed over documents faked just for the agency's inspection—and admitted it.